Connection
Jennifer Diamond to Drug-Related Side Effects and Adverse Reactions
This is a "connection" page, showing publications Jennifer Diamond has written about Drug-Related Side Effects and Adverse Reactions.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.026 |
|
|
|
-
Chiorean EG, LoRusso P, Strother RM, Diamond JR, Younger A, Messersmith WA, Adriaens L, Liu L, Kao RJ, DiCioccio AT, Kostic A, Leek R, Harris A, Jimeno A. A Phase I First-in-Human Study of Enoticumab (REGN421), a Fully Human Delta-like Ligand 4 (Dll4) Monoclonal Antibody in Patients with Advanced Solid Tumors. Clin Cancer Res. 2015 Jun 15; 21(12):2695-703.
Score: 0.026